Target intelligence / Profile preview

SRSF6 pseudogene 2 (SRSF6P2)

Target
SRSF6P2
Molecular classification
Other (Pseudogene)
01

Overview

SRSF6P2, or SRSF6 pseudogene 2, is a classified pseudogene and is not known to encode a functional protein or have direct biological or pathophysiological functions[5]. Pseudogenes such as SRSF6P2 are typically non-coding DNA sequences that resemble known genes but carry mutations or deletions that prevent normal expression or function; they do not serve as receptors, enzymes, or other typical drug targets in pharmacology[5]. No evidence suggests SRSF6P2 is directly involved in cellular processes or disease mechanisms, nor are there known drugs or therapeutic applications targeting this sequence. Errors arise if SRSF6P2 is confused with SRSF6 (Serine/arginine-rich splicing factor 6), a functional and disease-relevant protein-coding gene extensively studied for its roles in alternative splicing, cancer, and other cellular processes[1][2][4]. Structured biomedical databases (e.g., GeneCards) specifically annotate SRSF6P2 as a pseudogene distinct from the functional SRSF6 gene[5].\n\nKey Points:\n- SRSF6P2 is only a pseudogene.\n- Does not encode any known protein.\n- Not a therapeutic target, receptor, enzyme, or biomarker.\n- No drug interactions or associated mechanisms of action.\n- No established disease roles or safety concerns.\n- Should not be listed among canonical therapeutic or functional targets.\n\nIf information on the functional SRSF6 gene is needed, it should be requested for Serine/arginine-rich splicing factor 6 (SRSF6), not SRSF6P2.

Other names
SRSF6P2

Beyond the preview

Go deeper on SRSF6 pseudogene 2 (SRSF6P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRSF6 pseudogene 2 (SRSF6P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call